Refine Search
(4)
(26)
(30)
(31)

Acute Heart Failure - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Heart Failure - Pipeline Review, H2 2016’, provides an overview of the Acute Heart Failure pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Acute ...

Vasculitis - Pipeline Review, H2 2016

  • $2,000
  • July 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Vasculitis - Pipeline Review, H2 2016’, provides an overview of the Vasculitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vasculitis, complete wit...

Hemorrhagic Shock - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hemorrhagic Shock - Pipeline Review, H2 2016’, provides an overview of the Hemorrhagic Shock pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hemorrhagi...

Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.

The report provides comprehensive information on the therapeut...

Portal Hypertension - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Portal Hypertension - Pipeline Review, H2 2016’, provides an overview of the Portal Hypertension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Portal...

Pre-Eclampsia - Pipeline Review, H2 2016

  • $2,000
  • August 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pre-Eclampsia - Pipeline Review, H2 2016’, provides an overview of the Pre-Eclampsia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pre-Eclampsia, com...

Acute Ischemic Stroke - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Ischemic Stroke - Pipeline Review, H2 2016’, provides an overview of the Acute Ischemic Stroke pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ac...

Septic Shock - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Septic Shock - Pipeline Review, H2 2016’, provides an overview of the Septic Shock pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Septic Shock, comple...

Chronic Heart Failure - Pipeline Review, H2 2016

  • $2,000
  • September 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H2 2016’, provides an overview of the Chronic Heart Failure pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ch...

Acute Coronary Syndrome - Pipeline Review, H2 2016

  • $2,000
  • November 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Coronary Syndrome - Pipeline Review, H2 2016’, provides an overview of the Acute Coronary Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development fo...

Resistant Hypertension - Pipeline Review, H2 2016

  • $2,000
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Resistant Hypertension - Pipeline Review, H2 2016’, provides an overview of the Resistant Hypertension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Intermittent Claudication - Pipeline Review, H1 2017

  • $2,000
  • February 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Intermittent Claudication - Pipeline Review, H1 2017’, provides an overview of the Intermittent Claudication pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Hypotension - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypotension - Pipeline Review, H2 2018’, provides an overview of the Hypotension pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hypotension, complete ...

Thromboembolism - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H2 2018’, provides an overview of the Thromboembolism pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thromboembolis...

Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2018’, provides an overview of the Coronary Artery Disease (CAD) (Ischemic Heart Disease) pipeline landscape.

The report provides comp...